Published in PLoS One on July 14, 2011
The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol (2012) 2.09
Fungal Hsp90: a biological transistor that tunes cellular outputs to thermal inputs. Nat Rev Microbiol (2012) 0.96
BioModels: Content, Features, Functionality, and Use. CPT Pharmacometrics Syst Pharmacol (2015) 0.94
Loss of function of myosin chaperones triggers Hsf1-mediated transcriptional response in skeletal muscle cells. Genome Biol (2015) 0.86
Aggregation, impaired degradation and immunization targeting of amyloid-beta dimers in Alzheimer's disease: a stochastic modelling approach. Mol Neurodegener (2012) 0.82
Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma. Hum Mol Genet (2014) 0.81
Transiently transfected purine biosynthetic enzymes form stress bodies. PLoS One (2013) 0.81
Computational modelling of the regulation of Insulin signalling by oxidative stress. BMC Syst Biol (2013) 0.80
The proteome profiles of the olfactory bulb of juvenile, adult and aged rats - an ontogenetic study. Proteome Sci (2015) 0.77
Mathematical modelling of metabolic regulation in aging. Metabolites (2015) 0.76
BiP clustering facilitates protein folding in the endoplasmic reticulum. PLoS Comput Biol (2014) 0.76
The Proteome Profiles of the Cerebellum of Juvenile, Adult and Aged Rats--An Ontogenetic Study. Int J Mol Sci (2015) 0.75
Modelling the molecular mechanisms of ageing. Biosci Rep (2017) 0.75
Accelerated Sensitivity Analysis in High-Dimensional Stochastic Reaction Networks. PLoS One (2015) 0.75
Proteomic analysis of saliva in HIV-positive heroin addicts reveals proteins correlated with cognition. PLoS One (2014) 0.75
The Impact of Mathematical Modeling in Understanding the Mechanisms Underlying Neurodegeneration: Evolving Dimensions and Future Directions. CPT Pharmacometrics Syst Pharmacol (2017) 0.75
The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics (2003) 32.92
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature (1996) 26.30
Impairment of the ubiquitin-proteasome system by protein aggregation. Science (2001) 11.51
COPASI--a COmplex PAthway SImulator. Bioinformatics (2006) 10.57
The free radical theory of aging matures. Physiol Rev (1998) 9.83
BioModels Database: a free, centralized database of curated, published, quantitative kinetic models of biochemical and cellular systems. Nucleic Acids Res (2006) 9.49
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature (2003) 7.69
Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med (2000) 6.25
Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev (2008) 6.18
Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi. Science (2005) 5.04
Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry (1998) 3.90
A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature (2006) 3.76
Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. J Biol Chem (2002) 3.70
Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol Syst Biol (2010) 3.27
The GSK3 hypothesis of Alzheimer's disease. J Neurochem (2007) 3.16
Redox signaling and the MAP kinase pathways. Biofactors (2003) 2.54
Repression of the heat shock factor 1 transcriptional activation domain is modulated by constitutive phosphorylation. Mol Cell Biol (1997) 2.32
Under cover: causes, effects and implications of Hsp90-mediated genetic capacitance. Bioessays (2004) 2.02
Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 beta. J Biol Chem (2001) 1.90
Akt and CHIP coregulate tau degradation through coordinated interactions. Proc Natl Acad Sci U S A (2008) 1.66
Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts. J Biol Chem (2010) 1.36
Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species. Antioxid Redox Signal (2008) 1.33
Protein degradation by the proteasome and its implications in aging. Ann N Y Acad Sci (2000) 1.33
Brain CHIP: removing the culprits in neurodegenerative disease. Trends Mol Med (2006) 1.27
Age-related changes in glutathione and glutathione-related enzymes in rat brain. Brain Res (2006) 1.23
Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part I--effects of proliferative senescence. FASEB J (2000) 1.20
Differential patterns of apoptosis in response to aging in Drosophila. Proc Natl Acad Sci U S A (2005) 1.19
Towards an e-biology of ageing: integrating theory and data. Nat Rev Mol Cell Biol (2003) 1.11
Proteolysis, free radicals, and aging. Free Radic Biol Med (2002) 1.09
Aging and molecular chaperones. Exp Gerontol (2003) 1.08
Modelling the actions of chaperones and their role in ageing. Mech Ageing Dev (2005) 1.07
Protein aggregation as a paradigm of aging. Biochim Biophys Acta (2009) 1.05
Preheating accelerates mitogen-activated protein (MAP) kinase inactivation post-heat shock via a heat shock protein 70-mediated increase in phosphorylated MAP kinase phosphatase-1. J Biol Chem (2005) 1.05
The role of glycogen synthase kinase 3 in the early stages of Alzheimers' disease. FEBS Lett (2008) 0.98
Chaperone overload is a possible contributor to 'civilization diseases'. Trends Genet (2001) 0.97
Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part II--aging of nondividing cells. FASEB J (2000) 0.96
Chaperone function and chaperone overload in the aged. A preliminary analysis. Exp Gerontol (2002) 0.93
An in silico model of the ubiquitin-proteasome system that incorporates normal homeostasis and age-related decline. BMC Syst Biol (2007) 0.91
Analysis of mechanistic pathway models in drug discovery: p38 pathway. Biotechnol Prog (2007) 0.89
Experimental and computational analysis of polyglutamine-mediated cytotoxicity. PLoS Comput Biol (2010) 0.80
Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle (2007) 2.78
Rescue and propagation of fully retargeted oncolytic measles viruses. Nat Biotechnol (2005) 2.40
Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells. J Biol Chem (2003) 1.75
PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17. Clin Cancer Res (2013) 1.22
Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease. Clin Exp Metastasis (2011) 1.14
Interaction of Hsp90 with the nascent form of the mutant epidermal growth factor receptor EGFRvIII. J Biol Chem (2002) 1.00
A pharmacodynamic study of the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in metastatic colorectal cancer patients. Clin Cancer Res (2003) 0.95
Induction of premature senescence by hsp90 inhibition in small cell lung cancer. PLoS One (2010) 0.94
PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1. Oncotarget (2013) 0.91
A phase II trial of ZD1839 (Iressa) 750 mg per day, an oral epidermal growth factor receptor-tyrosine kinase inhibitor, in patients with metastatic colorectal cancer. Invest New Drugs (2005) 0.89
Coordination of glioblastoma cell motility by PKCι. Mol Cancer (2010) 0.88
Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle (2009) 0.86
Activation of p38MAPK contributes to expanded polyglutamine-induced cytotoxicity. PLoS One (2008) 0.77
Detection of PIK3CA Mutations in Breast Cancer Bone Metastases. ISRN Oncol (2012) 0.76
Atypical PKCι as target for glioblastoma therapy. Curr Cancer Drug Targets (2015) 0.75